Mundipharma
Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients
July 3, 2020Medical Communications, Research and Development Europe, Mundipharma, invokana
European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …
Mundipharma names Marc Princen as Global Chief Executive Officer
June 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment
Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …
Pharma firms paid Italian doctor to promote opioid drugs
May 29, 2019Research and Development Italy, Mundipharma, Purdue, opioids, pharma
Opioid drugmakers paid an Italian pain doctor to promote opioid painkillers as a treatment for chronic pain, Italian prosecutors say. …
Top Ten most popular articles on Pharmafile.com this week!
May 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics
Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …
Ex-GSK, Novartis exec named as Mundipharma’s Head of Access
May 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma
Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …
Pharma in 2018: Looking back, looking forward
December 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma
2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …
The December issue of Pharmafocus is available to read online now!
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma
The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
Mundipharma’s Neulasta biosimilar approved in EU
November 26, 2018Sales and Marketing Amgen, EU, Europe, Mundipharma, Neulasta, Pelmeg, pharma
Mundipharma has revealed that Pelmeg, its biosimilar version of Amgen’s Neulasta (pegfilgrastim), has been awarded marketing approval by the European …
Top Ten most popular articles on Pharmafile.com this week!
November 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10
The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …
Mundipharma name GSK veteran as new Senior Vice President & CFO
November 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president
The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …
Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma
November 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia
“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
Sackler-owned Mundipharma acquires biosimilar firm Cinfa Biotech
October 10, 2018Research and Development Mundipharma, biosimilar, cinfa biotech, sackler
In a bid to strengthen their biosimilar portfolio, the Cambridge based pain management company Mundipharma has acquired biosimilar development firm …
Mundipharma signs Chinese licensing and distribution agreement with Grünenthal
January 16, 2018Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …
Mundipharma names new President and CEO
December 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Napp, Napp Pharmaceuticals, appointment
Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …
Mundipharma names Philippe Mazas as new Chief Information Officer
December 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Philippe Mazas
Mundipharma has announced that it has appointed Philippe Mazas as its new Chief Information Officer (CIO). Mazas boasts nearly 20 …
Latest content
FibroFind appoints Lee Borthwick as CEO
